
Disitamab vedotin (RC48) is an антитело-препарат conjugate (ADC) comprising a моноклональный антитело against human epidermal growth factor рецептор 2 (HER2) conjugated via a cleavable linker to the cytotoxic agent monomethyl auristatin E. Disitamab vedotin enhances antitumor immunity.
Disitamab vedotin (RC48) is an antibody-drug conjugate (ADC) comprising a monoclonal antibody against human epidermal growth factor receptor 2 (HER2) conjugated via a cleavable linker to the cytotoxic agent monomethyl auristatin E. Disitamab vedotin enhances antitumor immunity.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.